Browse by category
260 million people in the US predicted to be living with overweight or obesity by 2050
ABS and AOBS agree Focused Practice Designation for metabolic and bariatric surgery examination
Gastric pouch resizing for recurrent weight gain promotes weight stabilisation in well-selected patients
COVID-19 pandemic: Bariatric surgery patients showed an increase in the percentage of weight regain
Semaglutide and liraglutide may reduce alcohol consumption in individuals with AUD
NK2R burns energy and lowers appetite without the nausea and vomiting
Adults with pre-diabetes and obesity or overweight treated with tirzepatide had sustained weight loss and nearly 99% remained diabetes-free at 176 weeks
Helix model can predict 12-month weight loss response of semaglutide in diverse populations
Journal Watch 13/11/2024
IFSO Bariatric Endoscopy Committee endorses endoscopic sleeve gastroplasty as an effective and valuable treatment for obesity